Clinical Trials
Bharat Biotech underplays adverse event in Covaxin Phase 1 trial as start date for Phase 3 nears
Bharat Biotech, during its phase 1 trials, experienced an adverse event in a volunteer that it did not promptly admit to the public. As per...
News
Oxford & AstraZeneca Covid-19 vaccine up to 90% effective, data shows
Preliminary results from an interim analysis of clinical trials of the ChAdOx1 nCoV-19 candidate show the vaccine is on average 70.4% effective at preventing Covid-19....
News
Chinese company seeks permission to launch covid vaccine for public use
A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market, seeking to get a jump on Western rivals...
News
Nearly a million receive injection of Sinopharm-developed vaccine, no serious adverse reactions
Vaccines developed by Chinese pharmaceutical company Sinopharm Group have now been used on nearly one million people, with no serious adverse reactions reported, and only...
News
Mexico aims to begin coronavirus vaccinations next month
Mexico said that it aims to start coronavirus vaccinations next month in the Latin American country, which has one of the world's highest COVID-19 death...
News
US will distribute 6.4 million COVID-19 vaccine doses in first tranche
The US plans to distribute 6.4 million doses of the Pfizer-BioNTech COVID-19 vaccine in the first week after it is cleared for emergency use, which...
News
EU Reaches Deal For Supply Of 160 Million Doses Of Moderna COVID-19 Vaccine
The European Union on Tuesday has reached a deal with drugmaker Moderna for the supply of its experimental coronavirus vaccine candidate, the head of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.